ロード中...
Safety and Tolerability of a Rapid Transition From Intravenous Treprostinil to Oral Selexipag in Three Adolescent Patients With Pulmonary Arterial Hypertension
There is limited published experience with transitioning pediatric patients from parenteral treprostinil to oral selexipag therapy. In addition, published transitions have typically been protracted, taking several weeks to complete. We present a case series of 3 adolescent patients who were transiti...
保存先:
| 出版年: | J Pediatr Pharmacol Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pediatric Pharmacy Advocacy Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8244952/ https://ncbi.nlm.nih.gov/pubmed/34239406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-26.5.512 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|